<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>650(8103)</volume><submitter>Wei HK</submitter><pubmed_abstract>Body-brain communication has emerged as a key regulator of tissue homeostasis&lt;sup>1-5&lt;/sup>. Solid tumours are innervated by different branches of the peripheral nervous system and increased tumour innervation is associated with poor cancer outcomes&lt;sup>6-8&lt;/sup>. However, it remains unclear how the brain senses and responds to tumours in peripheral organs, and how tumour-brain communication influences cancer immunity. Here we identify a tumour-brain axis that promotes oncogenesis by establishing an immune-suppressive tumour microenvironment. Combining genetically engineered mouse models with neural tracing, tissue imaging and single-cell transcriptomics, we demonstrate that lung adenocarcinoma induces innervation and functional engagement of vagal sensory neurons, a major interoceptive system connecting visceral organs to the brain. Mechanistically, Npy2r-expressing vagal sensory nerves transmit signals from lung tumours to brainstem nuclei, driving elevated sympathetic efferent activity in the tumour microenvironment. This, in turn, suppresses anti-tumour immunity via β&lt;sub>2&lt;/sub> adrenergic signalling in alveolar macrophages. Disruption of this sensory-to-sympathetic pathway through genetic, pharmacological or chemogenetic approaches significantly inhibited lung tumour growth by enhancing immune responses against cancer. Collectively, these results reveal a bidirectional tumour-brain communication involving vagal sensory input and sympathetic output that cooperatively regulate anti-cancer immunity; targeting this tumour-brain circuit may provide new treatments for visceral organ cancers.</pubmed_abstract><journal>Nature</journal><pagination>1007-1016</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC12935554</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Tumour-brain crosstalk restrains cancer immunity via a sensory-sympathetic axis.</pubmed_title><pmcid>PMC12935554</pmcid><pubmed_authors>Ichise H</pubmed_authors><pubmed_authors>Chang RB</pubmed_authors><pubmed_authors>Germain RN</pubmed_authors><pubmed_authors>Wang RL</pubmed_authors><pubmed_authors>Jin C</pubmed_authors><pubmed_authors>Zeng X</pubmed_authors><pubmed_authors>Wang Y</pubmed_authors><pubmed_authors>Wei HK</pubmed_authors><pubmed_authors>Hu B</pubmed_authors><pubmed_authors>Li L</pubmed_authors><pubmed_authors>Yu CD</pubmed_authors></additional><is_claimable>false</is_claimable><name>Tumour-brain crosstalk restrains cancer immunity via a sensory-sympathetic axis.</name><description>Body-brain communication has emerged as a key regulator of tissue homeostasis&lt;sup>1-5&lt;/sup>. Solid tumours are innervated by different branches of the peripheral nervous system and increased tumour innervation is associated with poor cancer outcomes&lt;sup>6-8&lt;/sup>. However, it remains unclear how the brain senses and responds to tumours in peripheral organs, and how tumour-brain communication influences cancer immunity. Here we identify a tumour-brain axis that promotes oncogenesis by establishing an immune-suppressive tumour microenvironment. Combining genetically engineered mouse models with neural tracing, tissue imaging and single-cell transcriptomics, we demonstrate that lung adenocarcinoma induces innervation and functional engagement of vagal sensory neurons, a major interoceptive system connecting visceral organs to the brain. Mechanistically, Npy2r-expressing vagal sensory nerves transmit signals from lung tumours to brainstem nuclei, driving elevated sympathetic efferent activity in the tumour microenvironment. This, in turn, suppresses anti-tumour immunity via β&lt;sub>2&lt;/sub> adrenergic signalling in alveolar macrophages. Disruption of this sensory-to-sympathetic pathway through genetic, pharmacological or chemogenetic approaches significantly inhibited lung tumour growth by enhancing immune responses against cancer. Collectively, these results reveal a bidirectional tumour-brain communication involving vagal sensory input and sympathetic output that cooperatively regulate anti-cancer immunity; targeting this tumour-brain circuit may provide new treatments for visceral organ cancers.</description><dates><release>2026-01-01T00:00:00Z</release><publication>2026 Feb</publication><modification>2026-07-10T03:22:12.803Z</modification><creation>2026-07-10T03:16:11.9Z</creation></dates><accession>S-EPMC12935554</accession><cross_references><pubmed>41639447</pubmed><doi>10.1038/s41586-025-10028-8</doi></cross_references></HashMap>